Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis

被引:167
作者
Brown, David A.
Sawchenko, Paul E.
机构
[1] Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA
[2] Fdn Med Res, La Jolla, CA 92037 USA
关键词
experimental allergic encephalomyelitis; microglia; myelin oligodendrocyte glycoprotein; neurodegeneration; nearoinflammation; T cell;
D O I
10.1002/cne.21307
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Murine models of experimental autoimmune encephalomyelitis (EAE) are important vehicles for studying the effects of genetic manipulation on disease processes related to multiple sclerosis (MS). Currently, a comprehensive assessment of EAE pathogenesis with respect to inflammatory and degenerating neuronal elements is lacking. By using Fluoro-jade histochemistry to mark neurodegeneration and dual immunostaining to follow T-cell, microglial, and vascular responses, the time course and distribution of pathological events in EAE was surveyed. C57BL/6J mice were killed at 7, 10, 14, 21 or 35 days after vaccination with the myelin oligodendrocyte glycoprotein peptide MOG(3-55). Disease onset occurred at day 14 and peaked at day 21. Early T-cell infiltration and microglial activation in periventricular and superficial white matter structures adjacent to meninges suggested initial recruitment of effector T cells via the cerebrospinal fluid and choroid plexus. This was associated with microglial activation at distal sites along the same white matter tracts, with subsequent vascular recruitment of T cells associated with further injury. Systematic examination of the entire CNS supported this two-step model of EAE pathogenesis, with inflammation and neurodegeneration commencing at similar times and affecting multiple levels of predominantly sensory central pathways, including their terminal fields. This included aspects of the visual, auditory/vestibular, somatosensory (lemniscal), and proprioceptive (spinocerebellar) systems. The early targeting of visual and periventricular structures followed by more widespread CNS involvement is consistent with common presenting signs in human MS patients and suggestive of a similar basis in neuropathology.
引用
收藏
页码:236 / 260
页数:25
相关论文
共 67 条
[1]   Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis [J].
Aharoni, R ;
Arnon, R ;
Eilam, R .
JOURNAL OF NEUROSCIENCE, 2005, 25 (36) :8217-8228
[2]   Motor neuron pathology in experimental autoimmune encephalomyelitis:: studies in THY1-YFP transgenic mice [J].
Bannerman, PG ;
Hahn, A ;
Ramirez, S ;
Morley, M ;
Bönnemann, C ;
Yu, S ;
Zhang, GX ;
Rostami, A ;
Pleasure, D .
BRAIN, 2005, 128 :1877-1886
[3]  
Barone C M, 1993, J Craniofac Surg, V4, P177, DOI 10.1097/00001665-199307000-00013
[4]   Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease [J].
Bjartmar, C ;
Wujek, JR ;
Trapp, BD .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 206 (02) :165-171
[5]   Antibodies to CD44 and integrin α4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment [J].
Brocke, S ;
Piercy, C ;
Steinman, L ;
Weissman, IL ;
Veromaa, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6896-6901
[6]  
BROWN A, 1982, LAB INVEST, V46, P171
[7]  
DAMJANAC M, 2006, BRAIN RES
[8]   Chemokines and chemokine receptors in autoimmune encephalomyelitis as a model for central nervous system inflammatory disease regulation [J].
Dogan, RNE ;
Karpus, WJ .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :1500-1505
[9]   A full genome search in multiple sclerosis [J].
Ebers, GC ;
Kukay, K ;
Bulman, DE ;
Sadovnick, AD ;
Rice, G ;
Anderson, C ;
Armstrong, H ;
Cousin, K ;
Bell, RB ;
Hader, W ;
Paty, DW ;
Hashimoto, S ;
Oger, J ;
Duquette, P ;
Warren, S ;
Gray, T ;
OConnor, P ;
Nath, A ;
Auty, A ;
Metz, L ;
Francis, G ;
Paulseth, JE ;
Murray, TJ ;
PrysePhillips, W ;
Nelson, R ;
Freedman, M ;
Brunet, D ;
Bouchard, JP ;
Hinds, D ;
Risch, N .
NATURE GENETICS, 1996, 13 (04) :472-476
[10]  
Eugster HP, 2001, EUR J IMMUNOL, V31, P2302, DOI 10.1002/1521-4141(200108)31:8<2302::AID-IMMU2302>3.0.CO